The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
Abstract
Objective. Recently, 2 classes of cytokine inhibitors have been defined at the molecular level. The largest group comprises the extracellular domains of cell surface cytokine receptors, and includes both tumor necrosis factor receptors (TNF‐R). The present study was conducted to investigate the role of TNF inhibitors in arthritis. Methods. We measured p55 and p75 soluble TNF‐R (sTNF‐R) in serum and synovial fluid (SF) samples from patients with rheumatic diseases and compared their levels with levels of soluble interleukin‐2 receptors (sIL‐2R). Sensitive enzyme‐linked immunosorbent assays (ELISA), specific for p55 and p75 sTNF‐R and for sIL‐2R, were used. Results. Serum levels of p75 sTNF‐R were 3–4‐fold higher than levels of p55 sTNF‐R, and both were significantly elevated in patients with osteoarthritis (OA) and rheumatoid arthritis (RA) compared with healthy controls. RA SF levels of sTNF‐R were 4–5‐fold higher than levels in serum, suggesting local production in the joint, and were significantly higher than levels in the SF of patients with seronegative arthropathy or OA. Furthermore, levels of p55 and p75 sTNF‐R, but not sIL‐2R or TNFα measured by ELISA, were increased in the SF of patients with clinically active RA. The soluble TNF‐R in RA and OA SF were functional since they inhibited TNF activity in a cytotoxicity assay in proportion to the levels of inhibitor present. Evaluation of serially obtained serum samples suggested that sTNF‐R may be a useful parameter for monitoring RA disease activity. Conclusion. Biologically active soluble TNF‐R are up‐regulated in patients with rheumatic disease and are produced locally in the joints. Measurement of serum levels of TNF‐R may be useful for monitoring of disease, and determination of SF levels could be of diagnostic value.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
revision of diagnostic criteria for rheumatoid arthritis
(2001) · Classic Papers in Rheumatology · doi:10.3109/9780203214237-47 · Cited by 2,237
1958 Revision of diagnostic criteria for rheumatoid arthritis
Ropes, M. W., Bennett, G. A., Cobb, S., Jacox, R., & Jessar, R. A. (1959) · Arthritis & Rheumatism · doi:10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9 · Cited by 1,999
Bertolini, D. R., Nedwin, G. E., Bringman, T. S., Smith, D. D., & Mundy, G. R. (1986) · Nature · doi:10.1038/319516a0 · Cited by 1,434
Dayer, J. M., Beutler, B., & Cerami, A. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.6.2163 · Cited by 1,216
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro.
Rubin, L. A., Kurman, C. C., Fritz, M. E., Biddison, W. E., Boutin, B., Yarchoan, R., & Nelson, D. L. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.5.3172 · Cited by 1,145
BRENNAN, F. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90430-3 · Cited by 1,129
Self-citationInterleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Gamble, J. R., Harlan, J. M., Klebanoff, S. J., & Vadas, M. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.24.8667 · Cited by 1,033
Molecular cloning and expression of a receptor for human tumor necrosis factor
Schall, T. J., Lewis, M., Koller, K. J., Lee, A., Rice, G. C., Wong, G. H. W., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 964
A Receptor for Tumor Necrosis Factor Defines an Unusual Family of Cellular and Viral Proteins
Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D., & Goodwin, R. G. (1990) · Science · doi:10.1126/science.2160731 · Cited by 959
Cited by
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
Feldmann, M., Brennan, F. M., & Maini, R. N. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.397 · Cited by 2,514
Self-citationCytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Moreland, L. W., Baumgartner, S. W., Schiff, M. H., Tindall, E. A., Fleischmann, R. M., Weaver, A. L., Ettlinger, R. E., Cohen, S., Koopman, W. J., Mohler, K., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707173370301 · Cited by 1,622
Lee, D. M., & Weinblatt, M. E. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06075-5 · Cited by 1,247
Pelletier, J.-P., Martel-Pelletier, J., & Abramson, S. B. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200106)44:6<1237::aid-art214>3.0.co;2-f · Cited by 1,072
Metadata
- Authors
- Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 1992-10
- Volume
- 35
- Issue
- 10
- Pages
- 1160-1169
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2039186692
- Cited by
- 337
- References
- 36
- FWCI
- 16.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. https://app.cochat.ai/papers/10.1002/art.1780351008
- The paper
- Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992). Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis & Rheumatism. https://doi.org/10.1002/art.1780351008
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.